Anti-atherosclerotic efficacy of olmesartan
- 24 April 2002
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (S2) , S7-S12
- https://doi.org/10.1038/sj.jhh.1001393
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic arteryThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Anti‐atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high‐cholesterol dietBritish Journal of Pharmacology, 1999
- Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of AtherosclerosisCirculation, 1999
- Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet.Hypertension Research, 1999
- Negative Regulation of Local Hepatocyte Growth Factor Expression by Angiotensin II and Transforming Growth Factor-β in Blood VesselsHypertension, 1998
- Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeysAtherosclerosis, 1998
- Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated AtherosclerosisCirculation, 1997
- Angiotensin II Increases Monocyte Binding to Endothelial CellsBiochemical and Biophysical Research Communications, 1996
- Pathobiology of atherosclerosis and plaque complicationsAmerican Heart Journal, 1994
- Effects of antihypertensive drugs on blood velocity in rhesus monkeys.Stroke, 1977